Skip to main content
. Author manuscript; available in PMC: 2021 Dec 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2020 Oct 28;409:115306. doi: 10.1016/j.taap.2020.115306

Table 2:

Arsenic-induced miRNA changes in in vivo models

Animal Strain, Tissue Arsenic Concentration & Time of Exposure Results miRNA Findings Reference
Wistar, liver 5 mg/kg bw, 14 and 28 days Liver toxicity and increased oxidative stress Up: miR-let7a, after 14 days
Down: miR-let7a, after 28 days, miR-146a
[56]
Sprague-Dawley, liver 0.1, 1, 10, or 100 mg/L sodium arsenite, 60 days Alteration of hepatic glutamate–cysteine ligase activity and glutathione levels Up: miR-151, miR-183, miR-148b and miR-192
Down: miR-26a, miR-423
[57]
C3H mice, liver Transplacental exposure to 42.5 and 85 ppm, gestational days 8–19 Differential DNA methylation 50 miRNAs altered at 42.5 ppm and 140 at 85 ppm
Validated-Up: miR-205, miR-203, miR-215, miR-34a
Down: miR-217
[59]
ApoE−/− mice, liver Transplacental exposure to 85 mg/L, gestational day 8 to birth Increased expression of inflammatory cytokine and heat shock protein 70. Elevated SREBP1 expression, and liver enzymes in plasma PND1 – Up: miR-361, miR-148a, miR-467a
Down: miR-let-7d, miR-719, miR-679, miR-592, miR-222, miR-497, miR-211, miR-188
PND70 – Up: miR-211, miR-291a-5p-291b-5p, miR-294, miR-302, miR-464
Down: miR-1, miR-10a, miR-15b, miR-214a, miR-130a, miR-149, miR-186, miR-193, miR-218, miR-337, miR-376a, miR-412, miR-476b, miR-681, miR-715
[63]